相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants
Roy N. Alcalay et al.
GENETICS IN MEDICINE (2014)
Recognizing the Right Not to Know: Conceptual, Professional, and Legal Implications
Graeme Laurie
JOURNAL OF LAW MEDICINE & ETHICS (2014)
From the Right to Know to the Right Not to Know INTRODUCTION
Bartha Maria Knoppers
JOURNAL OF LAW MEDICINE & ETHICS (2014)
A comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism
Joanne Trinh et al.
NEUROBIOLOGY OF AGING (2014)
Genetics and genomic medicine in Israel
Joel Zlotogora
MOLECULAR GENETICS & GENOMIC MEDICINE (2014)
Communication of Clinically Useful Next-Generation Sequencing Results to At-Risk Relatives of Deceased Research Participants: Toward Active Disclosure? Reply
Martijn P. Lolkema et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Parkinson's disease in patients and obligate carriers of Gaucher disease
Joanna G. Becker et al.
PARKINSONISM & RELATED DISORDERS (2013)
Sting of Alzheimer's failures offset by upcoming prevention trials
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2012)
Genetic testing legislation in Western Europe-a fluctuating regulatory target
Sirpa Soini
JOURNAL OF COMMUNITY GENETICS (2012)
Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease
Nir Giladi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Kin-Cohort Analysis of LRRK2-G2019S Penetrance in Parkinson's Disease
Stefano Goldwurm et al.
MOVEMENT DISORDERS (2011)
Mood and Cognition in Leucine-Rich Repeat Kinase 2 G2019S Parkinson's Disease
Vicki Shanker et al.
MOVEMENT DISORDERS (2011)
PICOGEN: Five years experience with a genetic counselling program for dementia
J. Fortea et al.
NEUROLOGIA (2011)
Genetic characteristics of leucine-rich repeat kinase 2 (LRRK2) associated Parkinson's disease
Soraya Bardien et al.
PARKINSONISM & RELATED DISORDERS (2011)
You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative
Misha Angrist
PERSONALIZED MEDICINE (2011)
Next-Generation Neurogenetics: The Future Has Begun PREFACE
Christine Klein
SEMINARS IN NEUROLOGY (2011)
Genetic Testing for Neurologic Disorders
Susanne A. Schneider et al.
SEMINARS IN NEUROLOGY (2011)
Disclosure of individual genetic data to research participants: the debate reconsidered
Annelien L. Bredenoord et al.
TRENDS IN GENETICS (2011)
LOW DISEASE RISK IN RELATIVES OF NORTH AFRICAN LRRK2 PARKINSON DISEASE PATIENTS
A. R. Troiano et al.
NEUROLOGY (2010)
Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain
L. Gao et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Interpersonal responses among sibling dyads tested for BRCA1/BRCA2 gene mutations
Heidi A. Hamann et al.
HEALTH PSYCHOLOGY (2008)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G. Healy et al.
LANCET NEUROLOGY (2008)
Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations
A. S. Chen-Plotkin et al.
NEUROLOGY (2008)
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
L. N. Clark et al.
NEUROLOGY (2006)
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease
Denise M. Kay et al.
GENETIC TESTING (2006)
LRRK2 mutations in Spanish patients with Parkinson disease -: Frequency, clinical features, and incomplete penetrance
C Gaig et al.
ARCHIVES OF NEUROLOGY (2006)
LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews
LJ Ozelius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
G2019S LRRK2 mutation in French and North African families with Parkinson's disease
S Lesage et al.
ANNALS OF NEUROLOGY (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
ZK Wszolek et al.
NEUROLOGY (2004)
分享论文
